Home › Trial NCT04387084
Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy
- Trial IDNCT04387084
- StatusActive Not Recruiting
- PhasePhase 1
- Study typeInterventional
- SponsorUniversity of Southern California
- Enrollment10
- Start date2020-08-12
- ConditionsAdvanced Malignant Skin Neoplasm · Metastatic Malignant Skin Neoplasm
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.